Literature DB >> 20672853

Comparison of the specific incorporation of intracrystalline proteins into urinary calcium oxalate monohydrate and dihydrate crystals.

Lauren A Thurgood1, Tingting Wang, Timothy K Chataway, Rosemary L Ryall.   

Abstract

The aim of this study was to compare the comprehensive intracrystalline protein profiles of calcium oxalate monohydrate (COM) and dihydrate (COD) crystals precipitated from the same human urine samples. Three separate batches of COM and COD crystals were precipitated from pooled healthy human urine by the addition of sodium oxalate at calcium concentrations of 2 and 8 mM, respectively. Proteins in whole extracts of demineralised COM and COD crystals, as well as in spots excised from 2D-PAGE gels of the extracts, were identified using liquid chromatography and tandem mass spectrometry (LC-MS/MS). The number and type of individual proteins differed between COM and COD: 14 substantive proteins were found inside COM crystal extracts and 34 inside COD, with 9 proteins occurring in both crystal types. Numerous keratins were detected. However, in line with consensus in the proteomics literature, as well as a lack of published evidence linking them to urolithiasis, they were excluded as contaminants, leaving very few consistently detected proteins. On the basis of their known association with stone disease or identification in multiple runs, the principal proteins in COM crystal extracts were prothrombin fragment 1, protein S100A9, and IGkappaV1-5, while those in extracts of COD crystals included osteopontin, IGkappaV1-5, protein S100A9, annexin A1, HMW kininogen-1, and inter-alpha-inhibitor (IalphaI). In general, proteins incorporated into both hydromorphs were acidic (pI<6), smaller than 55 kDa, and calcium binders. We concluded that the incorporation of proteins into urinary COM and COD crystals is selective and that only a few of the urinary proteins associated with the two hydromorphs are likely to play any significant role in stone pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20672853     DOI: 10.1021/pr100467z

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.

Authors:  Archana Chidambaram; Douglas Rodriguez; Saeed Khan; Laurie Gower
Journal:  Urolithiasis       Date:  2014-08-15       Impact factor: 3.436

Review 3.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

4.  Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts.

Authors:  Douglas E Rodriguez; Taili Thula-Mata; Edgardo J Toro; Ya-Wen Yeh; Carl Holt; L Shannon Holliday; Laurie B Gower
Journal:  Acta Biomater       Date:  2013-10-17       Impact factor: 8.947

5.  Label-free proteomic methodology for the analysis of human kidney stone matrix composition.

Authors:  Frank A Witzmann; Andrew P Evan; Fredric L Coe; Elaine M Worcester; James E Lingeman; James C Williams
Journal:  Proteome Sci       Date:  2016-02-27       Impact factor: 2.480

6.  Alpha-enolase on apical surface of renal tubular epithelial cells serves as a calcium oxalate crystal receptor.

Authors:  Kedsarin Fong-Ngern; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

7.  Proteomic analysis reveals some common proteins in the kidney stone matrix.

Authors:  Yuanyuan Yang; Senyuan Hong; Cong Li; Jiaqiao Zhang; Henglong Hu; Xiaolong Chen; Kehua Jiang; Fa Sun; Qing Wang; Shaogang Wang
Journal:  PeerJ       Date:  2021-07-27       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.